Adenomatoid hyperplasia of mucous salivary glands. Report of two cases

Our plain-English summary of Adenomatoid hyperplasia of mucous salivary glands. Report of two cases, by F.H. Brown, G.D. Houston, R.M. Lubow, et al (Journal of Periodontology, 1987).

The study

• Authors: F.H. Brown, G.D. Houston, R.M. Lubow, M.A. Sagan
• Journal: Journal of Periodontology
• Published: 1987;58(2):125-7
• Type of article: Case report
• Cited by: 11 articles, as counted by NIH iCite
• Read it: PubMed · Publisher

Abstract

Adenomatoid hyperplasia of the mucous salivary glands is an uncommon benign tumor of the oral cavity. Two cases of palatal involvement are presented. Since clinical differentiation between benign and malignant growth of the palate cannot be established, microscopic examination is necessary. The palate is the most common location of this lesion, and as such it is useful for the periodontist to be aware of this tumor.

In plain English

This article reported two cases of adenomatoid hyperplasia of the mucous salivary glands. The authors described this as an uncommon benign tumor-like overgrowth of the minor salivary glands, usually found in the palate. The first patient, a 22-year-old man, had a lesion in the right soft palate with recurrent swelling and discomfort that got worse with swallowing and chewing. It was removed under general anesthesia. The specimen measured 0.9 x 0.8 x 0.6 cm, and microscopic examination diagnosed adenomatoid hyperplasia of mucous salivary gland. The second patient, a 31-year-old man, had a mass without symptoms in the right palate near the first and second molars, noticed during a routine examination. It was removed under local anesthesia, healing was uneventful, and the same diagnosis was made. The authors noted that the cause of this condition is unknown. They concluded that the lesion cannot be told apart from salivary gland tumors, including malignant ones, by clinical examination alone. It should therefore be removed and examined under a microscope, and surgical removal appears to be the treatment of choice.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Case report (two cases)
• Who was studied: Two men, aged 22 and 31, referred to a Department of Periodontics (the authors were at United States Air Force medical facilities), each with a lesion of the palate
• Main results:
  • Case 1: a 22-year-old man had a lesion in the right soft palate
  • Case 1: the removed specimen measured 0.9 x 0.8 x 0.6 cm
  • Case 1: the microscopic diagnosis was adenomatoid hyperplasia of mucous salivary gland
  • Case 2: a 31-year-old man had a mass in the right palate near the first and second molars, found on routine clinical examination
  • Case 2: after removal under local anesthesia, healing was uneventful
  • Case 2: the same diagnosis of adenomatoid hyperplasia of mucous salivary glands was made
  • The authors stated that the cause of this focal enlargement of the minor salivary glands is unknown
• The authors' conclusion: The authors concluded that, because this lesion cannot be distinguished clinically from salivary gland neoplasms, it should be excised and examined microscopically. They stated that surgical excision appears to be the treatment of choice and that the condition is not reported to recur.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Mesothelioma.

Medical terms in this study, explained in our Lexicon: Adenomatoid Tumor.

Related studies

• Labial salivary gland assessment in idiopathic pulmonary fibrosis patients with sicca symptoms — M. Bawazir, S. Cha, et al. (2021)
• Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers — D.W. Henderson, G. Reid, et al. (2013)
• Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review — D.W. Henderson, K.B. Shilkin, et al. (1998)
• Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia — J.T. Rabban, P. Vohra, et al. (2015)
• Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia — M. Yoshimura, Y. Kinoshita, et al. (2019)
• Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets — E.G. Ramírez-Salazar, L.C. Salinas-Silva, et al. (2014)

Browse return to medical research.